|
🐜
|
Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular arrhythmias.
13 auth.
K. Yiu,
A. Schouffoer,
N. Marsan,
M. Ninaber,
J. Stolk,
T. V. Vlieland,
R. Scherptong,
V. Delgado,
E. Holman,
H. Tse,
...
T. Huizinga,
Jeroen J. Bax,
A. Schuerwegh
|
6 |
2011 |
6
🐜
|
|
🦁
|
Impaired sexual function in women with systemic sclerosis: a cross-sectional study.
8 auth.
A. Schouffoer,
J. V. D. Marel,
M. Kuile,
P. Weijenborg,
A. Voskuyl,
C. V. Vlieland,
...
J. V. Laar,
T. Vlieland
|
6 |
2009 |
6
🦁
|
|
🐜
|
Predicting cardiopulmonary involvement in patients with systemic sclerosis: complementary value of nailfold videocapillaroscopy patterns and disease-specific autoantibodies
11 auth.
I. Markusse,
J. Meijs,
B. de Boer,
J. Bakker,
H. Pascal C. Schippers,
A. Schouffoer,
...
N. Ajmone Marsan,
L. Kroft,
M. Ninaber,
T. Huizinga,
J. D. de Vries-Bouwstra
|
6 |
2016 |
6
🐜
|
|
🦁
|
Randomized comparison of a multidisciplinary team care program with usual care in patients with systemic sclerosis
13 auth.
A. Schouffoer,
M. Ninaber,
L. B. D. Voorde,
F. Giesen,
Z. Jong,
J. Stolk,
A. Voskuyl,
R. Scherptong,
J. Laar,
J. Laar,
...
A. Schuerwegh,
T. Huizinga,
T. Vlieland
|
5 |
2011 |
5
🦁
|
|
🦁
|
Needs and preferences regarding health care delivery as perceived by patients with systemic sclerosis
7 auth.
A. Schouffoer,
E. Zirkzee,
S. Henquet,
M. Caljouw,
G. Steup-Beekman,
J. V. van Laar,
...
T. V. Vlieland
|
5 |
2011 |
5
🦁
|
|
🐜
|
Effectiveness of Nonpharmacologic Interventions in Systemic Sclerosis: A Systematic Review
9 auth.
L. Willems,
J. Vriezekolk,
A. Schouffoer,
J. Poole,
T. Stamm,
C. Boström,
...
L. Kwakkenbos,
T. V. Vliet Vlieland,
C. V. D. van den Ende
|
5 |
2015 |
5
🐜
|
|
🐜
|
Rituximab in early systemic sclerosis
11 auth.
M. Boonstra,
J. Meijs,
A. Dorjée,
N. Marsan,
A. Schouffoer,
M. Ninaber,
...
K. Quint,
F. Bonte‐Mineur,
T. Huizinga,
H. Scherer,
J. D. de Vries-Bouwstra
|
5 |
2017 |
5
🐜
|
|
🐜
|
Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosis
9 auth.
J. Meijs,
A. Schouffoer,
N. Ajmone Marsan,
L. Kroft,
T. Stijnen,
M. Ninaber,
...
T. Huizinga,
T. V. Vliet Vlieland,
J. D. de Vries-Bouwstra
|
5 |
2016 |
5
🐜
|
|
🐜
|
Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study
16 auth.
S. V. van Bijnen,
J. D. de Vries-Bouwstra,
C. V. D. van den Ende,
M. Boonstra,
L. Kroft,
B. Geurts,
M. Snoeren,
A. Schouffoer,
J. Spierings,
J. V. van Laar,
...
T. Huizinga,
A. Voskuyl,
E. Marijt,
W. J. van der Velden,
F. V. D. van den Hoogen,
M. Vonk
|
5 |
2019 |
5
🐜
|
